Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia

Grzegorz Helbig (1) , Andrzej Moskwa (2) , Marek Hus (3) , Jarosław Piszcz (4) , Alina Swiderska (5) , Alina Urbanowicz (6) , Małgorzata Całbecka (7) , Ilona Seferyńska (8) , Małgorzata Raźny (9) , Marek Rodzaj (9) , Ewa Żuk (10) , Sławomira Kyrcz-Krzemień (1)

1 Departament of Haematology and Bone Marrow Transplantation
2 Department of Haematology
3 Department of Haematology
4 Department of Haematology
5 Department of Haematology
6 Department of Haematology
7 Department of Haematology
8 Institute of Haematology and Transfusion Medicine
9 Department of Haematology and Internal Medicine
10 Department of Haematology

Mots clés: Medicine

Domaines: Cancer

Grzegorz Helbig, Andrzej Moskwa, Marek Hus, Jarosław Piszcz, Alina Swiderska, et al.. Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia. Cancer Chemotherapy and Pharmacology, 2011, 67 (4), pp.967-969. ⟨10.1007/s00280-011-1582-3⟩. ⟨hal-00671228⟩